Tocilizumab use in patients with moderate to severe COVID‐19: a retrospective cohort study

S Chilimuri, H Sun, A Alemam, KS Kang… - Journal of Clinical …, 2021 - Wiley Online Library
What is known and objective The coronavirus disease 2019 (COVID‐19) associated
cytokine activation can lead to a rapid progression into respiratory failure, shock and …
被引用次数：18 相关文章

Tocilizumab use in patients with moderate to severe COVID-19: A retrospective cohort study.

S Chilimuri, H Sun, A Alemam, KS Kang… - Journal of Clinical …, 2020 - europepmc.org
Methods We examined the association between tocilizumab use and intubation or death at a
community hospital in New York City. Data were obtained regarding consecutive patients …

Tocilizumab use in patients with moderate to severe COVID-19: A retrospective cohort study

S Chilimuri, H Sun, A Alemam… - Journal of clinical …, 2021 - pubmed.ncbi.nlm.nih.gov
What is known and objective The coronavirus disease 2019 (COVID-19) associated cytokine
activation can lead to a rapid progression into respiratory failure, shock and multiorgan …

Tocilizumab use in patients with moderate to severe COVID‐19: A retrospective cohort study.

S Chilimuri, H Sun, A Alemam… - Journal of Clinical …, 2021 - search.ebscohost.com
What is known and objective: The coronavirus disease 2019 (COVID‐19) associated
cytokine activation can lead to a rapid progression into respiratory failure, shock and …

Tocilizumab use in patients with moderate to severe COVID-19: a retrospective cohort study.

S Chilimuri, H Sun, A Alemam, KS Kang, P Lao… - 2020 - cabidigitallibrary.org
What is known and objective: The coronavirus disease 2019 (COVID-19) associated
cytokine activation can lead to a rapid progression into respiratory failure, shock and …